Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area gpcr g protein leukotriene receptor'

Search results for: 'research area gpcr g protein leukotriene receptor'

Items 21-30 of 52

Page
per page
  1. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  2. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  3. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL
  4. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/InsR inhibitor,potent and selective
      ≥23.05 mg/mL
  5. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  6. Silvestrol
    A3818 Silvestrol
    Summary: Antineoplastic
      Soluble in DMSO
  7. 1-NM-PP1
    B1299 1-NM-PP1
    Target: Cyclin-Dependent Kinases|Bcr-Abl|Src|Ca2 /calmodulin-dependent protein kinases (CaMKs)|c-Fyn
    Summary: Pp60c-src inhibitor
      insoluble in H2O; ≥16.55 mg/mL
  8. IRAK inhibitor 1
    A3500 IRAK inhibitor 1
     2 Citation
    Target: IRAK
    Summary: IRAK-4 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥14.4 mg/mL
  9. Afatinib (BIBW2992)
    A8247 Afatinib (BIBW2992)
     1 Citation
    Target: EGFR
    Summary: Irreversible EGFR/HER2 inhibitor
      ≥24.3 mg/mL
  10. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive
      ≥36.6 mg/mL

Items 21-30 of 52

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Axl 2item
  2. ALK 4item
  3. Broad Spectrum Protein Kinase Inhibitor 1 item
  4. c-FMS 1 item
  5. c-Kit 2item
  6. c-MET 4item
  7. c-RET 2item
  8. CSF-1R 1 item
  9. EGFR 7item
  10. EphB4 1 item
  11. FAK 4item
  12. FGFR 3item
  13. FLT3 2item
  14. HER2 3item
  15. IGF1R 3item
  16. IRAK 2item
  17. PDGFR 7item
  18. Pyk2 2item
  19. Spleen Tyrosine Kinase (Syk) 1 item
  20. Src 2item
  21. Tie-2 1 item
  22. Trk 3item
  23. VEGFR 11item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 2item
  3. CSF-1R 1 item
  4. FLT3 2item
  5. Eph Receptors 1 item
  6. VEGFR 13item
  7. PDGFR 9item
  8. c-Kit 6item
  9. RET 1 item
  10. IRAK 2item
  11. Bcr-Abl 2item
  12. FGFR 4item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 2item
  15. Src 1 item
  16. Trk Receptors 2item
  17. EGFR 5item
  18. FAK 4item
  19. BMP and Other Activin Receptors 3item
  20. Syk 1 item
  21. ErbB 2item
  22. c-MET 2item
  23. PKC 1 item
  24. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  25. Lyn 1 item
  26. HER2 1 item
  27. Pyk2 3item
  28. S1P receptors 1 item
  29. Insulin and Insulin-like Receptors 2item
  30. PKG 1 item
  31. PKA 1 item
  32. Myosin light chain kinases (MLCKs) 1 item
  33. c-Fyn 1 item
  34. AXL 1 item
  35. c-Fms tyrosine kinase 1 item
  36. tropomyosin receptor kinase 1 item
Reported Experiments
  1. Animal Experiments 45item
  2. Cell Experiments 23item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 3item
  5. Breast Cancer 11item
  6. Cancer 39item
  7. Cervical Cancer 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Colon Cancer 1 item
  10. Colon Carcinoma 1 item
  11. Colorectal Cancer 9item
  12. Glioblastoma 4item
  13. Glioma 1 item
  14. Hepatocellular Carcinoma 2item
  15. Liver Cancer 2item
  16. Lung Cancer 5item
  17. Lung Carcinoma 1 item
  18. Lymphoma 1 item
  19. Melanoma 2item
  20. Multiple Myeloma 4item
  21. Myeloma 1 item
  22. Non-small Cell Lung Cancer 4item
  23. Ovarian Cancer 5item
  24. Pancreatic Cancer 6item
  25. Prostate Cancer 4item
  26. Pulmonary Arterial Hypertension 1 item
  27. Renal Cell Carcinoma 2item
  28. Thyroid Cancer 1 item